Nisa Investment Advisors, LLC Uro Gen Pharma Ltd. Transaction History
Nisa Investment Advisors, LLC
- $29.3 Billion
- Q4 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 464 shares of URGN stock, worth $11,289. This represents 0.0% of its overall portfolio holdings.
Number of Shares
464
Previous 652
28.83%
Holding current value
$11,289
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding URGN
# of Institutions
170Shares Held
44.3MCall Options Held
1.61MPut Options Held
433K-
Rtw Investments, LP New York, NY4.54MShares$111 Million1.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.22MShares$103 Million2.65% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$77.6 Million0.1% of portfolio
-
Morgan Stanley New York, NY2.53MShares$61.5 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$53.5 Million0.21% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $553M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...